cd38 inhibitor and 5-amino-1mq synergy nad+ CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents Frontiers | Nicotinamide N-methyltransferase (NNMT):
Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Inhibition of CD38 enzymatic activity enhances CAR T cell immune therapeutic efficacy by repressing glycolytic metabolism ScienceDirect The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Small Molecule CD38 Inhibitors: Synthesis of 8 Amino N1 inosine 5 monophosphate, Analogues and Early Structure Activity Relationship
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



